A Change in the Epidemiology of Infections Due to Extended-Spectrum -Lactamase--Producing Organisms
Author(s) -
R.-B. Jesus,
David L. Paterson
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/500945
Subject(s) - broad spectrum , medicine , chemistry , combinatorial chemistry
Potential conflicts of interest. D.L.P. received recent research funding from Pfizer, Elan, AstraZeneca, Merck; serves as a consultant forMerck, Wyeth, Elan, and AstraZeneca; and serveson the speakers’ bureau for Merck, Elan, Cubist,and AstraZeneca. J.R.B.: no conflicts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom